Announcement of Hubei Jichuan Pharmaceutical Co., Ltd. on the subsidiary obtaining a drug registration certificate
Announcement of the progress of Hubei Jichuan Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding transactions
Announcement of Hubei Jichuan Pharmaceutical Co., Ltd. on repurchasing shares for the first time through centralized bidding
Special report on the deposit and actual use of funds raised by Hubei Jumpcan Pharmaceutical Co., Ltd. in the first half of 2024
Announcement of the resolution of the 11th meeting of the 10th Supervisory Board of Hubei Jumpcan Pharmaceutical Co., Ltd.
Hubei Jumpcan Pharmaceutical Co., Ltd. 2024 Interim Report
Summary of the semi-annual report of Hubei Jumpcan Pharmaceutical Co., Ltd. for 2024
Announcement of the resolution of the 11th meeting of the 10th board of directors of Hubei Jumpcan Pharmaceutical Co., Ltd.
Announcement of Hubei Jumpcan Pharmaceutical Co., Ltd. on its subsidiary's participation in the subscription of fund shares.
Announcement of Partial Options Cancellation of the Restricted Stocks and Stock Options Incentive Plan for 2022 of Hubei Jumpcan Pharmaceutical Co., Ltd.
Legal Opinion of Guohao Law Firm (Shanghai) on the Cancellation of Restricted Stock Options and Repurchase of Restricted Stocks of Hubei Jumpcan Pharmaceutical Co., Ltd.'s 2022 Restricted Stock and Stock Option Incentive Plan.
Announcement of Hubei Jumpcan Pharmaceutical Co., Ltd. on the implementation of the cancellation of restricted share buyback of 2022 restricted stock and stock option incentive plan.
Announcement on the Progress of Repurchasing Shares by Hubei Jumpcan Pharmaceutical Co., Ltd. through Centralized Competitive Trading
Announcement from Hubei Jumpcan Pharmaceutical Co., Ltd. regarding share buyback: Shareholding status of the top ten shareholders and the top ten unrestricted shareholders.
Hubei Jumpcan Pharmaceutical: Announcement from Hubei Jumpcan Pharmaceutical Co., Ltd. regarding repurchasing and cancelling restricted stocks and reducing registered capital, notifying creditors.
Hubei Jumpcan Pharmaceutical: Verification opinion of the Supervisory Board of Hubei Jumpcan Pharmaceutical Co., Ltd. on the cancellation of part of the stock options and repurchase of part of the restricted stocks for cancellation.
Hubei Jumpcan Pharmaceutical: Announcement of the resolutions of the 10th meeting of the 10th Board of Directors of Hubei Jumpcan Pharmaceutical Co., Ltd.
Hubei Jumpcan Pharmaceutical: Announcement of the resolution of the 10th Supervisory Board Meeting of Hubei Jumpcan Pharmaceutical Co., Ltd.
Hubei Jumpcan Pharmaceutical: Announcement on cancellation of some stock options and repurchase of restricted stocks by Hubei Jumpcan Pharmaceutical Co., Ltd.
Hubei Jumpcan Pharmaceutical: Legal opinion from Guohao Law Firm (Shanghai) regarding the cancellation of some stock options and repurchase of restricted stocks under Hubei Jumpcan Pharmaceutical Co., Ltd.'s 2022 restricted stock and stock option incentive plan.
No Data
No Data